Write in a clean editor, then format for npj Vaccines in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
npj Vaccines is a peer-reviewed journal published by Springer Nature, covering SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Influenza Virus Research Studies. Over its lifetime it has published 1,511 papers, which have received 35,380 citations.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. npj Vaccines 12, 45–58 (2023).
Formats any DOI in npj Vaccines style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses Influenza Virus Research Studies Mosquito-borne diseases and control Viral gastroenteritis research and epidemiology |
| ISSN | 2059-0105 |
| Citation impact (2-yr) | 6.18 |
| h-index | 81 |
| i10-index | 772 |
| Article processing charge | $3,170 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | National Institute of Allergy and Infectious Diseases |
| Journal website | www.nature.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The new SARS-CoV-2 virus is an RNA virus that belongs to the Coronaviridae family and causes COVID-19 disease. The newly sequenced virus appears to originate in China and rapidly spread throughout the world, becoming a pandemic that, until January 5th, 2021, has caused more than 1,866,000 deaths. Hence, laboratories worldwide are developing an effective vaccine…
Recent advances in several areas are rekindling interest and enabling progress in the development of therapeutic cancer vaccines. These advances have been made in target selection, vaccine technology, and methods for reversing the immunosuppressive mechanisms exploited by cancers. Studies testing different tumor antigens have revealed target properties that yield high tumor versus normal cell specificity…
Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccination can lead to needle fear, long-term negative attitudes and non-compliant behaviours, which undermine the…
mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understanding of quality attributes that dictate translation efficiency, as well as a comprehensive appreciation of the importance of…
Aluminum-containing adjuvants have been used for over 90 years to enhance the immune response to vaccines. Recent work has significantly advanced our understanding of the physical, chemical, and biological properties of these adjuvants, offering key insights on underlying mechanisms. Given the long-term success of aluminum adjuvants, we believe that they should continue to represent the…
